| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $148.1M | -9.5% |
| Cost of Revenue | $38.0M | -17.8% |
| Gross Profit | $110.1M | -6.3% |
| R&D Expense | $36.3M | -11.8% |
| SG&A Expense | $46.4M | -5.5% |
| Operating Income | -$50.7M | +18.3% |
| Pre-tax Income | -$41.5M | +18.2% |
| Income Tax | $633K | -36.4% |
| Net Income | -$42.2M | +18.6% |
| EPS (Basic) | -$1.01 | +12.9% |
| EPS (Diluted) | -$1.01 | +12.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.9M | -71.9% |
| Accounts Receivable | $28.6M | -24.6% |
| Current Assets | $228.3M | -10.0% |
| Total Assets | $251.0M | -10.5% |
| Current Liabilities | $88.2M | -8.2% |
| Total Liabilities | $91.5M | -8.5% |
| Stockholders' Equity | $159.4M | -11.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.8M | +139.4% |
| Capital Expenditures | $2.2M | +2.7% |
| Investing Cash Flow | -$19.5M | -112.0% |
| Financing Cash Flow | -$23.3M | +81.3% |
| Free Cash Flow | $2.6M | +117.8% |